NCT04913246

Brief Summary

Sepsis represents by its frequency, its morbidity and mortality and its cost to society a major public health issue with a constantly increasing incidence. It affects millions of people around the world each year and is the 2nd leading cause of death in intensive care units. The incidence of sepsis has been estimated by the World Health Organization (WHO), based on US data, at 15 to 19 million cases of sepsis per year worldwide.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
430

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2014

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 25, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
Last Updated

January 4, 2023

Status Verified

January 1, 2023

Enrollment Period

5.1 years

First QC Date

May 25, 2021

Last Update Submit

January 3, 2023

Conditions

SepsisEmergencies

Keywords

SepsisseverityprognosistriageMortalty

Outcome Measures

Primary Outcomes (1)

  • Mortality

    one month

Secondary Outcomes (1)

  • Mortality and /or readmission

    one year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

each patient diagnosed as an acute Sepsi consulting the emergencies of CHU Sahloul, Sousse

You may qualify if:

  • Age \>18 years old
  • each patient diagnosed as an acute Sepsi consulting the emergencies of CHU Sahloul, Sousse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SepsisEmergencies

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Study Officials

  • Riadh Boukef, professor

    CHU Sahloul, Sousse, Tunisia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PROFESSOR

Study Record Dates

First Submitted

May 25, 2021

First Posted

June 4, 2021

Study Start

March 1, 2014

Primary Completion

March 31, 2019

Study Completion

March 31, 2019

Last Updated

January 4, 2023

Record last verified: 2023-01